Jett, L., Lger, R., Thibaudeau, K., Benquet, C., Robitaille, M., Pellerin, I., Paradis, V., van Wyk, P., Pham, K., & Bridon, D
However, anecdotal reports from patients taking compounded tirzepatide suggest the feeling often emerges within the first 48 weeks and typically resolves as the body adapts to its new weight and metabolic baseline
Bernstein analyst Courtney Breen said the FDAs decision suggests that the end of compounder-spree was near, but that this will have only a modest impact on the drugs prescription volumes in 2025
However, individuals should be cautious as some international pharmacies are not legitimate or licensed
Who Should NOT Take HRT History of hormone-receptor-positive breast cancer History of blood clots (DVT or pulmonary embolism) Active or history of endometrial cancer Undiagnosed vaginal bleeding Active liver disease Known or suspected pregnancy Uncontrolled hypertension Our Approach to Female HRT Comprehensive Consultation We discuss your symptoms, menstrual history, health history, family history (including breast cancer and cardiovascular disease), current medications, and goals
